TickerFactsScreenerDevelopers

OCULAR THERAPEUTIX, INC (OCUL) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2012: $203.0K2013: $387.0K2014: $1.26M2015: $1.78M2016: $1.92M2017: $8.25M2018: $1.89M2019: $2.24M2020: $841.0K2021: $1.19M2022: $3.71M2023: $6.09M2024: $1.29M2025: $12.01M$12.01M
2012Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$12.01M+832.5%
2024$1.29M-78.8%
2023$6.09M+63.8%
2022$3.71M+211.1%
2021$1.19M+42.0%
2020$841.0K-62.4%
2019$2.24M+18.5%
2018$1.89M-77.1%
2017$8.25M+330.0%
2016$1.92M+7.9%
2015$1.78M+41.1%
2014$1.26M+225.6%
2013$387.0K+90.6%
2012$203.0K—